- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Roche pledges nearly $300M to establish new Vabysmo production plant in China | ||
| 08.05. | Argenx brews up DTC push for Vyvgart Hytrulo prefilled syringe in generalized myasthenia gravis | ||
| 08.05. | FDA misses another approval decision target date, this time for GSK's Nucala in COPD | ||
| 08.05. | In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen | ||
| 08.05. | Trump to sign 'most favored nation' executive order to slash drug prices for Medicare: Politico | ||
| 08.05. | Takeda looks toward 'inflection point' as it eyes new launches to shake off Vyvanse generic impacts | ||
| 08.05. | Amneal bolsters US manufacturing capacity with Apiject collaboration deal | ||
| 08.05. | Teva plots thousands of job cuts as restructuring drive enters 'acceleration' phase | ||
| 08.05. | Gilead tees up $11B in new US manufacturing, R&D investments | ||
| 07.05. | Moderna faces PMCPA audit over 'completely unacceptable' lack of transparency | ||
| 07.05. | J&J survey finds pace of oncology innovation is overwhelming physicians | ||
| 07.05. | AstraZeneca, Daiichi Sankyo's Enhertu rings up success in another breast cancer trial | ||
| 07.05. | Xellia to shutter Copenhagen antibiotics plant, dealing a blow to EU reshoring efforts | ||
| 07.05. | Novo's Wegovy takes a hit from compounders, but company expects faster second-half growth | ||
| 06.05. | Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia | ||
| 06.05. | FDA commissioner Marty Makary taps Vinay Prasad to head up CBER | ||
| 06.05. | Neurocrine holds on to branded tardive dyskinesia push with help from Wilson Phillips star | ||
| 06.05. | 'Now is not the time to retreat': BMS CEO blasts Trump admin tariffs, health reforms amid $40B US investment pledge | ||
| 06.05. | Trump signs executive order to boost US drug manufacturing amid threat of tariffs | ||
| 06.05. | Incyte, Novartis agree to settle long-running Jakafi royalty dispute just before trial | ||
| 06.05. | Havas Life opens Dubai office to serve 'thriving' Middle East and North Africa region | ||
| 06.05. | AstraZeneca debuts $300M cell therapy manufacturing facility in Maryland | ||
| 05.05. | Ex-Moderna brand chief Kate Cronin joins Medtronic Diabetes as marketing head | ||
| 05.05. | US net drug spending surged 11.4% last year, boosted by obesity and oncology meds: IQVIA | ||
| 05.05. | AbbVie's Skyrizi retakes top TV ad spending spot for the first time all year |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .